Philadelphia

Kirkland & Ellis Expands Philadelphia Footprint with New Pharmaceutical Litigation Pro

by

Kirkland, Washington — Kirkland & Ellis LLP is expanding its Philadelphia office, signaling a strong commitment to growth in the competitive legal market. The firm recently bolstered its presence by hiring a seasoned litigator with expertise in pharmaceutical and medical device liability cases. This move comes several months after the firm initially established its footprint in the city. The addition of this litigator underscores Kirkland & Ellis’ strategy to cater to the needs of clients in the life sciences sector, an industry that faces increasing scrutiny and legal challenges. The new hire brings a wealth … Read more

Philadelphia Braces for Landmark Mass Torts Trials: What to Expect in 2025

by

Philadelphia is preparing for a series of significant mass tort trials set to unfold in 2025, amid growing concerns over public health and safety. These complex legal proceedings are expected to draw considerable attention as they tackle wide-ranging issues, particularly those related to product liability and environmental hazards. The trials will center around claims from residents who allege that certain products and substances have caused serious harm. Among the key players are pharmaceutical companies facing lawsuits from individuals who contend that medications have resulted in severe adverse health effects. The legal battles could set precedents, … Read more

Pfizer Withdraws Request for Depo-Provera Litigation Coordination in Philadelphia Amid Lack of New Cases

by

Philadelphia — A coordinated mass tort regarding Depo-Provera, Pfizer Inc.’s injectable contraceptive, will not proceed in the city for now. The pharmaceutical giant has recently withdrawn its request for the Philadelphia Court of Common Pleas to establish a consolidated litigation program concerning this contraceptive, citing an unexpected lack of new lawsuits. Pfizer’s decision comes after expectations of a significant increase in legal filings surrounding the product failed to materialize. The company’s initial proposal aimed to streamline the process for addressing multiple claims against Depo-Provera, but the anticipated surge in litigation has not occurred. Depo-Provera, a … Read more

Potential Mass Tort Emerges in Philadelphia as Depo-Provera Lawsuits Link Injectable Contraceptive to Brain Tumors

by

PHILADELPHIA — Legal proceedings surrounding the injectable contraceptive Depo-Provera could soon be consolidated into a mass tort, a move prompted by multiple lawsuits linking the medication to brain tumors. The potential coordination aims to streamline the legal process for the plaintiffs, who have raised serious concerns about the drug’s safety profile. Last week, Pfizer Inc., the manufacturer responsible for the branded version of Depo-Provera, formally requested that the Philadelphia Court of Common Pleas manage these cases collectively. This would allow the court to address the various claims against the drug and its authorized generic counterparts … Read more